These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
224 related articles for article (PubMed ID: 9445832)
41. Strontium as therapy for osteoporosis. Marie PJ Curr Opin Pharmacol; 2005 Dec; 5(6):633-6. PubMed ID: 16183330 [TBL] [Abstract][Full Text] [Related]
42. Fluoride therapy of type I osteoporosis. Devogelaer JP; Nagant de Deuxchaisnes C Clin Rheumatol; 1995 Sep; 14 Suppl 3():26-31. PubMed ID: 8846658 [TBL] [Abstract][Full Text] [Related]
43. [Therapy of senile osteoporosis using sodium fluoride--continuous and intermittent long-term therapy]. Haber P; Willvonseder R Schweiz Med Wochenschr; 1979 May; 109(18):688-92. PubMed ID: 107583 [TBL] [Abstract][Full Text] [Related]
44. Effect of slow-release sodium fluoride on cancellous bone histology and connectivity in osteoporosis. Zerwekh JE; Hagler HK; Sakhaee K; Gottschalk F; Peterson RD; Pak CY Bone; 1994; 15(6):691-9. PubMed ID: 7873299 [TBL] [Abstract][Full Text] [Related]
45. Sodium fluoride therapy of postmenopausal osteoporosis. Kleerekoper M; Mendlovic DB Endocr Rev; 1993 Jun; 14(3):312-23. PubMed ID: 8319597 [TBL] [Abstract][Full Text] [Related]
46. [Therapy of osteoporosis with fluorides and calcitonins]. Ringe JD Internist (Berl); 1991 Feb; 32(2):80-9. PubMed ID: 2032792 [No Abstract] [Full Text] [Related]
50. Fluoride pharmacokinetics in good and poor responders to fluoride therapy. Kraenzlin ME; Kraenzlin C; Farley SM; Fitzsimmons RJ; Baylink DJ J Bone Miner Res; 1990 Mar; 5 Suppl 1():S49-52. PubMed ID: 2339636 [TBL] [Abstract][Full Text] [Related]
51. [Osteoporosis therapy and thyroid function. Influence of 6 months of sodium fluoride treatment on thyroid function and bone density]. Eichner R; Börner W; Henschler D; Köhler W; Moll E Fortschr Med; 1981 Mar; 99(10):342-8. PubMed ID: 7216100 [TBL] [Abstract][Full Text] [Related]
52. [Problems of high dose sodium fluoride treatment in osteoporosis. 2. The effect of fluorides on the human skeleton]. Heidelmann G Z Arztl Fortbild (Jena); 1979 Jun; 73(11):526-9. PubMed ID: 473799 [No Abstract] [Full Text] [Related]
53. [Current aspects of fluoride therapy of osteoporosis]. Abendroth K Wien Med Wochenschr; 1990 Oct; 140(18-19):482-4. PubMed ID: 2251841 [TBL] [Abstract][Full Text] [Related]
54. [Sociomedical significance and restabilization therapy of osteoporosis (author's transl)]. Krokowski E; Fricke M MMW Munch Med Wochenschr; 1975 Oct; 117(44):1775-8. PubMed ID: 810712 [TBL] [Abstract][Full Text] [Related]
56. [Multiple bony fissures during treatment of osteoporosis with sodium fluoride]. Glimet T; Kuntz D; de Vernejoul MC; Ryckewaert A Rev Rhum Mal Osteoartic; 1980 Oct; 47(10):581. PubMed ID: 7209354 [No Abstract] [Full Text] [Related]
57. [Treatment of common osteoporosis with fluoride: current trends]. Kuntz D Rev Rhum Mal Osteoartic; 1992 Jan; 59(1):39-45. PubMed ID: 1579845 [TBL] [Abstract][Full Text] [Related]
58. Fluoride therapy for osteoporosis: a review of dose response, duration of treatment, and skeletal sites of action. Dure-Smith BA; Kraenzlin ME; Farley SM; Libanati CR; Schulz EE; Baylink DJ Calcif Tissue Int; 1991; 49 Suppl():S64-72. PubMed ID: 1933602 [TBL] [Abstract][Full Text] [Related]